US Probes Shire's Marketing For Adderall, Others

Law360, New York (October 30, 2009, 2:08 PM EDT) -- British drugmaker Shire PLC has received a subpoena from U.S. investigators seeking documents related to the sales and marketing of three drugs, including Adderall, the company said.

In its third quarter results released Friday, Shire disclosed that it received the subpoena on Sept. 23 from the office of the inspector general at the U.S. Department of Health and Human Services in coordination with the U.S. Attorney's Office for the Eastern District of Pennsylvania.

The subpoena seeks documents related to three Shire drugs: Adderall XR, Daytrana and...
To view the full article, register now.